GERN

Geron Corporation · NASDAQ

Sector Health Technology
Industry Biotechnology
Website geron.com
Employees(FY) 107
ISIN US3741631036

Performance

+11.81%

-18.86%

-52.82%

-64.5%

-59.89%

YTD

-60.11%

Profile

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. Geron Corporation was incorporated in 1990 and is headquartered in Foster City, California.

Advanced Technical Analysis

Technical Analysis of GERN 2025-04-25

The stock indicators reflect a mixed sentiment, with the Moving Average Score at 41 indicating a neutral outlook, the Oscillators Score at 54 suggesting a slightly positive bias, and the overall Technical Score at 47 reinforcing a neutral stance. This combination implies that while there are some bullish signals, the overall market sentiment rem...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of GERN

Stock Rank

Recent News & Updates

2025-04-06 20:00
ClearBridge Small Cap Growth Strategy Q1 2025 Commentary(Seekingalpha)
2025-04-03 16:21
GERN Securities Lawsuit Filed Against Geron Corporation- Contact the DJS Law Group to Discuss Your Rights(Prnewswire)
2025-03-31 04:32
Geron Corp.: A Compelling Potential Buying Opportunity Thanks To Bearish Comments(Seekingalpha)
2025-03-31 04:30
Geron Plans to Announce First Quarter 2025 Financial Results on May 7, 2025(Businesswire)
2025-03-31 02:34
Biotech Stocks Q1 2025 Recap: Winners And Underperformers(Seekingalpha)
2025-03-27 21:30
GERN Securities Lawsuit Filed Against Geron Corporation- Contact the DJS Law Group to Discuss Your Rights(Prnewswire)
2025-03-25 05:52
Geron Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - GERN(Prnewswire)
2025-03-25 05:43
Is Geron Corporation (NASDAQ:GERN) The Top Penny Stock That Will Skyrocket?(Insidermonkey)
2025-03-21 01:43
Geron Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before May 12, 2025 to Discuss Your Rights GERN(Globenewswire)
2025-03-20 17:45
Geron Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before May 12, 2025 to Discuss Your Rights - GERN(Prnewswire)
2025-03-19 04:30
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)(Businesswire)
2025-03-17 17:45
Shareholders of Geron Corporation Should Contact Levi & Korsinsky Before May 12, 2025 to Discuss Your Rights - GERN(Prnewswire)
2025-03-11 04:30
Geron Announces European Commission Approval of RYTELO (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adults With Transfusion-Dependent Anemia Due to Lower-Risk MDS(Businesswire)
2025-03-11 04:02
Geron Corporation Announces Departure of Chief Executive Officer(Businesswire)
2025-02-25 18:30
Geron Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights(Businesswire)
2025-02-20 20:00
Geron to Participate at Upcoming Investor Conferences in March 2025(Businesswire)
2025-02-19 03:15
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)(Businesswire)
2025-02-03 09:00
Geron to Announce Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025(Business Wire)
2025-02-02 20:00
Geron to Announce Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025(Businesswire)
2025-01-27 14:05
Geron (NASDAQ:GERN) shareholder returns have been stellar, earning 169% in 3 years(Simply Wall St.)
2025-01-21 16:30
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)(Business Wire)
2025-01-21 03:30
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)(Businesswire)
2024-12-31 13:04
High Growth Tech Stocks to Watch in December 2024(Simply Wall St.)
2024-12-27 20:52
Geron Corp. (GERN) Ends Trading Week Defying Market Bloodbath(Insidermonkey)
2024-12-19 16:30
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)(Business Wire)
2024-12-19 03:30
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)(Businesswire)
2024-12-18 13:19
Geron Corporation (NASDAQ:GERN) is a favorite amongst institutional investors who own 72%(Simply Wall St.)
2024-12-14 06:40
Geron announces positive CHMP opinion for Rytelo(TipRanks)
2024-12-13 06:36
Geron Announces Positive CHMP Opinion for RYTELO™ (imetelstat) for the Treatment of Adults with Transfusion-Dependent Anemia due to Lower-Risk MDS(Business Wire)
2024-12-12 17:36
Geron Announces Positive CHMP Opinion for RYTELO (imetelstat) for the Treatment of Adults with Transfusion-Dependent Anemia due to Lower-Risk MDS(Businesswire)

Page 1 of 5

previousnext

Disclaimer: The information provided here and on kavout.com is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout makes no recommendations regarding investment decisions based on this information. You are solely responsible for your investments. Please conduct your own research and consult qualified financial advisors before investing. Past performance does not guarantee future results.